Up-regulation of CD64 Expression on Monocytes in Patients With Active Adult-Onset Still Disease
- 9 November 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JCR: Journal of Clinical Rheumatology
- Vol. 26 (2), 67-72
- https://doi.org/10.1097/rhu.0000000000000931
Abstract
In this study, we investigated whether monocyte CD64 (mCD64) expression is correlated with disease activity in patients with adult-onset Still disease (AOSD) and whether it could be used to distinguish between active and inactive disease states. We reviewed a series of 10 patients with a definite diagnosis of AOSD, recruited from January 2013 to December 2016. We used flow cytometry to quantitatively measure mCD64 expression levels in patients presenting with active and inactive disease states and statistically analyzed the corresponding changes. The mean ± SD values of mCD64 expression levels in patients with active and inactive disease states were 77,148.3 ± 39,066.3 and 19,225.8 ± 7006.2 molecules/cell, respectively, indicating significantly higher mCD64 expression in the active state than in the inactive state (p = 0.005). Receiver operating characteristic analysis with a cutoff value of 31,796.0 molecules/cell was applied to distinguish active from inactive disease states; the sensitivity and specificity were both 100%. In these patients, only the mCD64 expression levels changed in parallel with disease activity under tocilizumab treatment; other conventional biomarkers measured showed no changes. Monocyte CD64 expression could be used to clearly distinguish between active and inactive AOSD. Thus, mCD64 could be a promising biomarker for evaluating the disease activity of AOSD, even in patients receiving tocilizumab treatment.Keywords
This publication has 30 references indexed in Scilit:
- Monochromatic gating method by flow cytometry for high purity monocyte analysisCytometry Part B: Clinical Cytometry, 2013
- Functional Characteristics of the High Affinity IgG Receptor, FcγRIThe Journal of Immunology, 2011
- Clinical Manifestations but not Cytokine Profiles Differentiate Adult-onset Still’s Disease and SepsisThe Journal of Rheumatology, 2010
- Type I interferons: crucial participants in disease amplification in autoimmunityNature Reviews Rheumatology, 2010
- Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupusArthritis Research & Therapy, 2009
- Cytokines in the pathogenesis of rheumatoid arthritisNature Reviews Immunology, 2007
- Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold valuesAnnals Of The Rheumatic Diseases, 2007
- Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6Clinical Immunology, 2006
- Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's diseaseAnnals Of The Rheumatic Diseases, 2004
- Adult‐onset still's diseaseArthritis & Rheumatism, 1987